512101 — Triochem Products Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Triochem Products, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 45.5 | -5.81 | 17.6 | -11.7 | -13.3 |
Depreciation | |||||
Non-Cash Items | 1.92 | 0.03 | -2.94 | -8.1 | -4.77 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -10.9 | 107 | 18.8 | 2.98 | -20.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 38.2 | 103 | 34.7 | -15.8 | -37.6 |
Capital Expenditures | -0.324 | -0.237 | -0.268 | 0 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.056 | 0.253 | 1.86 | -92.7 | 33.4 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.268 | 0.016 | 1.59 | -92.7 | 33.4 |
Financing Cash Flow Items | -2.01 | -1.09 | -0.152 | 0 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -34.9 | -26.1 | -0.152 | 0 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.04 | 76.4 | 36.1 | -109 | -4.21 |